Opioids in Serious Medical Illness
|
|
- Allen McDaniel
- 6 years ago
- Views:
Transcription
1 Opioids in Serious Medical Illness Jacob J. Strand, M.D. Assistant Professor of Medicine Medical Director, Palliative Care Clinical Services Mayo Clinic Mayo Clinic Opioid Conference 2013 MFMER slide-1
2 DISCLOSURE Speaker (Dr. J.J.Strand) Relevant Financial Relationship(s) None related to this talk Off Label Use Opioids for dyspnea 2013 MFMER slide-2
3 Objectives Choose safe prescribing options for opioids in the treatment of non-pain symptoms. Develop a step-wise approach to the use of opioids in patients with liver & renal failure Prevent avoidable side effects in patients with a serious illness who are being treated with opioids MFMER slide-3
4 Case 1 A 62-year-old male, with a complex past medical history including chronic myofascial low back pain, diabetes mellitus and severe chronic obstructive pulmonary disease on 4L home oxygen therapy presents to your outpatient clinic with ongoing severe dyspnea on exertion. He has struggled with repeated hospitalizations for his dyspnea and is now unable to play with his grandchildren due to the dyspnea of this minimal exertion. While reasonably comfortable at rest, he develops increasing dyspnea ambulating in your office, describing an inability to catch my breath associated with anxiety MFMER slide-4
5 Case 1 Afterwards, he is visibly tachypneic and using accessory muscles of respiration. Vitals signs reveal a temperature of 37.9, respiratory rate of 32, heart rate of 104 and pulse oximetry at 93% on 4L/min of oxygen by nasal cannula. Pulmonary examination exhibits a prolonged expiratory phase and intermittent scattered rhonchi throughout his lung fields, with hyperresonance to percussion. Jugular venous pressure is measured at 6cm of water at 45 degree bed angle MFMER slide-5
6 Which one of the following interventions is most appropriate to treat her dyspnea? A. Start fentanyl 25 micrograms with 2mL saline via home nebulizer four times daily as needed B. Start lorazepam 0.25mg PO BID as needed for dyspnea C. Increase his home oral furosemide D. Start oxycodone 2.5mg PO q4hrs as needed for dyspnea E. Increase oxygen by nasal cannula to 5 liters/minute 2013 MFMER slide-6
7 Answer D. Start oxycodone 2.5mg PO q4hrs as needed for dyspnea MFMER slide-7
8 Dyspnea Complex, uncomfortable sensation that includes air hunger, increased effort or work of breathing, and chest tightness Self report is the gold standard for assessment Use 0-10 scale Neural structures involved in pain and dyspnea may be shared Nishino T. Br J Anaesth. 2011;106(4): Campbell ML. AACN Adv Crit Care. 2011;22(3): MFMER slide-8
9 BONUS PEARL: Non-pharmacologic strategies for Dyspnea Proper positioning & pursed-lip breathing Gait aids (e.g. walkers) Fans: RCT in refractory dyspnea After 5 minutes with handheld fan, statistically significant decrease in breathlessness Guided meditation/relaxation training Acupuncture Oxygen? Galbraith S et al. J Pain Symptom Manage. 2010;39(5): Greer JA et al., J Pain Symptom Manage Jul 10. [epub ahead of print] Abernethy et al., Lancet Sep 4;376(9743): MFMER slide-9
10 Opioids Are First Line Pharmacotherapy Improve subjective sensations of dyspnea and are safe when dosed appropriately for properly selected patients. Class effect: No data to support morphine as superior to other opioids Parshall MB et al., Am J Respir Crit Care Med Feb 15;185(4): Coyne PJ et al. J Pain Symptom Manage. 2002;23(2): MFMER slide-10
11 Opioids for Dyspnea Starting doses In an opioid-naïve patient: Morphine 5 to 7.5 mg PO every 4 hours Oxycodone 2.5 to 5 mg PO every 4 hours Hydromorphone 1 to 2 mg PO every 3 hors Long acting opioids: Class effect Increase no more frequently than every week Good data in Morphine SR 10-20mg PO qam Abernathy AP et al. BMJ. 2003;327(7414): Currow DC et al., J Palliat Med Aug;16(8): MFMER slide-11
12 Management of Dyspnea Inhaled opioids no more beneficial than placebo in controlled trials. Appropriately dosed opioids should NOT cause respiratory depression MFMER slide-12
13 Take Home Points In patients with severe dyspnea, appropriately dosed opioids are first-line therapy for symptomatic relief MFMER slide-13
14 Case 2 BL is a 67yoM with a past medical history of diabetes mellitus & end-stage renal disease on hemodialysis for the past 4 years with recently diagnosed cirrhosis, secondary to previous alcohol use (now sober x10yrs). He also carries a diagnosis of metastatic prostate adenocarcinoma with diffuse spinal metastases, but his disease is currently stable on androgen deprivation therapy. He presents for follow-up in your outpatient practice for increasing back pain. He describes the pain as a deep aching sensation in his low-back with painful burning in his buttocks & thighs bilaterally MFMER slide-14
15 Case 2 Imaging shows no evidence of malignant spinal cord compression. He does have evidence of some nonmalignant spinal stenosis levels L3-L5. Of note, he has not responded to previous attempts at epidural steroid injections tried at numerous juncture in the past. The pain affects his ability to walk & perform most ADLs. He has been tried on a number of analgesics including acetaminophen, up to 3grams/day, gabapentin which caused confusion & morphine which made him too sleepy MFMER slide-15
16 What is the next best option for managing this patient s pain? A. Tramadol 50mg PO q6hrs prn pain B. Hydromorphone 2mg PO q4hrs prn pain C. Ibuprofen 600mg PO q8hrs prn pain D. Fentanyl patch 25mcg/hr changed every 72hrs E. Oxycodone 7.5mg PO q4hrs prn pain 2013 MFMER slide-16
17 Answer B. Hydromorphone 2mg PO q4hrs prn pain 2013 MFMER slide-17
18 The right dose is the dose that provides adequate pain relief with acceptable side effects MFMER slide-18
19 There is a Tension Between Safety and Appropriate Analgesia Patients Report Inadequate Analgesia as Persistent Fear Present in most serious illnesses. Over 1/3 of patients with cancer do not receive analgesia according to their need. Pain impairs quality of life and function which can adversely affect survival. Greco MT et al., J Clin Oncol Dec 20;32(36): MFMER slide-19
20 In patients with serious illness nonopioid adjuvants often carry their own safety concerns. And, there are safe ways to use opioids in these patients MFMER slide-20
21 Renal Failure & Opioids Toxic metabolites accumulate Morphine Hydromorphone Increased ½ life of many drugs Tramadol Oxycodone Variability in ability to dialyze opioids Methadone & fentanyl = no Morphine & tramadol = yes King S et al., Palliat Med Jul;25(5): Dean M., J Pain Symptom Manage Nov;28(5): MFMER slide-21
22 Cirrhosis & Opioids Protein Bound Opioid Free Drug Metabolic pathways Clearance of metabolites Increased drug ½ life Variable onset of analgesia Increased effect in heavily protein bound drugs Increased generation of toxic metabolites. Chandok N & Watt KD. Mayo Clin Proc May;85(5): Dwyer JP et al., J Gastroenterol Hepatol. 2014;29(7): MFMER slide-22
23 Opioid Protein Binding Metabolism Morphine Mod/high Liver (glucuronidation) bioavailable w/liver failure & toxic metabolites Hydrocodone Low Liver CYP2D6 time to onset in liver failure Pearl 1. Avoid in Renal failure 2. Avoid in hepatic failure or cirrhosis 1. Variable efficacy; combination w/acetaminophen limits use. Oxycodone Mod/high Liver CYP 2D6/3A4 Half life in liver failure Hydromorphone Low Liver (glucuronidation) generation of toxic metabolites 1. Increased ½ life & variable onset 2. If used, reduce dose & frequency 1. Better choice if renal insufficiency. 2. Reduce dose & frequency in liver failure/cirrhosis Fentanyl High Liver CYP3A4 bioavailable w/liver failure Tramadol Low/mod Liver CYP 2D6/3A4 1. Safest long-acting drug in renal and liver failure. 2. Start lower dose patch in liver failure 1. Variable time to onset & analgesic efficacy in liver failure 2. Interactions w/other serotonergic medications MFMER slide-23
24 A Revised Pain Ladder for Patients with Renal Disease & Liver Failure/Cirrhosis Hydromorphone Gabapentin/Pregabalin Oxycodone (IR/CR forms) Fentanyl TD Referral to Specialist for Interventions Methadone Acetaminophen Topicals Functional assessment & referral to appropriate services at each step MFMER slide-24
25 Take Home Points In patients with severe renal impairment/dialysis, hydromorphone appears to be the safest short acting opioid. Opioids in liver failure can be used but need to start at lower doses and longer intervals Fentanyl patches can provide safer long-acting analgesia Morphine, codeine, tramadol all to be avoided 2013 MFMER slide-25
26 Case 3 BS is a 82-year-old female with moderate Alzheimer s dementia admitted to your hospital after a ground-level fall at her skilled care facility. She has a history of essential hypertension (well-controlled on amlodipine) & stage IV chronic kidney disease (basedline creatinine 2.1g/dL). Initial evaluation reveals displaced, left femoral neck fracture and she proceeds with surgical fixation. You are consulted by the surgical team to assist with medical management MFMER slide-26
27 Case 3 The patient has been receiving hydromorphone 2mg PO q6 hours on a standing basis & acetaminophen 1000mg PO q8hrs. Her other medications including amlodipine and donepezil are continued, and PRN orders are also placed: senna for constipation, albuterol nebulization solution for wheezing, zolpidem for sleep. Pain appears to be initially well-controlled, but on postoperative day 2, you are called to evaluate the patient for altered mentation. You find her agitated and actively hallucinating. Vital signs: Blood pressure 135 mmhg / 82 mmhg, and respiratory rate 16/min at rest with pulse oximetry at 94% on room air MFMER slide-27
28 While evaluating causes of her delirium, which of the following in the most correct next step in the management of her pain? A. Discontinue hydromorphone & replace with ibuprofen 400 mg every 6 hours for the next 48 hours. B. Discontinue hydromorphone & replace with tramadol 50 mg orally every 6 hours for pain. C. Decrease hydromorphone & start lidocaine patch x2 over left hip. D. Continue hydromorphone E. Discontinue hydromorphone & give lorazepam 0.25 mg IV once for agitation MFMER slide-28
29 Answer D. Continue hydromorphone 2013 MFMER slide-29
30 Opioids in the Elderly Patient Increased prevalence of renal and hepatic dysfunction. Increased sensitivity to opioid therapy Greater concern for drug-drug interactions Balance-Falls-Oh My! Watch those anticholinergic effects 2013 MFMER slide-30
31 A Revised Pain Ladder for Elderly Patients with Pain & a Serious Illness? Extended-release opioids Fentanyl TD Acetaminophen Topicals Referral to Specialist for Interventions Low dose hydromorphone or oxycodone Duloxetine Pregabalin Functional assessment & referral to appropriate services at each step MFMER slide-31
32 Take Home Points Opioids may be a cause of altered mental status in elderly patients with pain, but other causes of delirium should be considered, particularly in patients who appear to have previously tolerated opioids MFMER slide-32
33 Case 4 SM is a 59yoF with a long history of Type I diabetes mellitus complicated by end-stage renal failure, now receiving hemodialysis. She was admitted to your service for management of her severe bilateral lower extremity pain secondary to known calciphylaxis. Despite aggressive interventions her lesions continue to progress leading to ongoing severe pain managed with oral oxycodone sustained release and immediate release formulations with additional IV fentanyl pushes for severe pain. After many discussions with her Nephrology and Dermatology teams, she decides to forgo further disease directed therapies and focus on her comfort, which includes discontinuation of her dialysis MFMER slide-33
34 Case 4 Her analgesic regimen is changed over to a morphine continuous infusion of 1mg/hr with additional 2mg IV boluses available by PCA. Overnight she develops worsening pain and her infusion is increased several times. She is also given several doses of IV lorazepam which seem to help transiently overnight. In the morning, she is agitated, confused and yelling out intermittently in pain. When asked about her pain, she is unable to respond but appears to have diffuse pain to even light touch. HR 124. RR 20. Blood pressure is 88/54. Morphine infusion is currently at 5mg/hr. Extremities reveal deep ulcerations of her lower extremities bilaterally with intermittent myoclonus MFMER slide-34
35 What is the best option in the management of this patient? A. Haloperidol 2mg IV q4hrs needed for agitation B. Increase morphine to 6mg/hr but add in 6mg IV q10min by nursing administered bolus as needed C. Discontinue the morphine and start lorazepam 2mg IV q4hrs D. Discontinue morphine and start a lower dose fentanyl infusion with nursing administered boluses as needed 2013 MFMER slide-35
36 Answer D. Discontinue morphine and start a lower dose fentanyl infusion with nursing administered boluses as needed 2013 MFMER slide-36
37 Morphine Delirium Agitation Myoclonus Seizures Morphine-3-Glucuronide Morphine-6-Glucuronide Morphine-3-Glucuronide 2013 MFMER slide-37
38 When Signaling Goes Wrong Despite Our Attempts to fix it Hyperalgesia Increased pain response from normally painful stimulus. Sensitization Increased pain response from normal (typically nonpainful) stimulus. + Beginnings of new neurons that will fire with smaller and smaller stimuli. Peripheral & Central phenomenon 2013 MFMER slide-38
39 Opioid Associated Neurotoxicity MANIFESTATIONS Increasing sedation Agitation & delirium Hallucinations Myoclonus Seizures TREATMENTS Opioid rotation Dose reduction Hydration, magnesium replacement Avoid Confounders Adjuvants 2013 MFMER slide-39
40 Take Home Points Hyperalgesia mechanisms complex but involve both NMDA & glutamate-mediated pathways as well as potential direct toxic effects of active opioid metabolites. Treatment is opioid rotation, adjuvant NMDA blockade & supportive care MFMER slide-40
41 Using Opioids In Serious Illness Partridge et al., J Clin Oncol Oct 10;32(29): by American Society of Clinical Oncology 2013 MFMER slide-41
42 Questions & To cure sometimes, relieve often, comfort always. Dr. Edward Trudeau 2013 MFMER slide-42
4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t
Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless
More informationPain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD
Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationOpioid Use in Serious Illness
Opioid Use in Serious Illness Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado
More informationOpioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1
Opioid Case Studies Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN September 29, 2016 2015 MFMER slide-1 Disclosures Relevant Financial Relationship(s) None Off Label and/or
More informationRegional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.
Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.
More information1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective
Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the
More informationOpioid Rotation. Dr Bruno Gagnon, M.D., M.Sc.
Opioid Rotation Dr Bruno Gagnon, M.D., M.Sc. Associate Professor Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval Consultant in Palliative Medicine CHU de Québec-Université
More informationOpioid Pearls and Acute Pain Management
Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program
More informationPain Management Management in Hepatic Hepatic and and Renal Dysfunction
Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction
More informationDyspnea. Stephanie Lindsay
Dyspnea Stephanie Lindsay What is dyspnea? An unpleasant sensation of difficult, labored breathing Shortness of air Dyspnea is not the same as tachypnea therefore patients may not present with rapid breathing
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationPalliative Emergencies. Ken Stakiw
Palliative Emergencies Ken Stakiw Disclosure None to disclose for this lecture Have received honoraria from a number of agencies and companies previously Intend to discuss some off label use of medications
More informationOPIOID- INDUCED NEUROTOXICITY*
OPIOID- INDUCED NEUROTOXICITY* Sriram Yennu MD, MS, FAAHPM Palliative Care, Rehabilitation and Integrative Medicine U.T. M.D. Anderson Cancer Center *Slide Deck courtesy Dept PRIM MDACC PATIENT #1: MRS
More informationApproach to Acute Pain Management
Approach to Acute Pain Management Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado
More informationAcute pain management in opioid tolerant patients. Muhammad Laklouk
Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)
More informationObjectives. Patient Controlled Analgesia (PCA) Management in the Seriously Ill. Discuss principles for opioid dosing and titration for acute pain
Patient Controlled Analgesia (PCA) Management in the Seriously Ill Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Associate Director, Colorado
More informationPAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC
PAIN MANAGEMENT PGY-1 Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC Perception Matters A builder aged 29 came to the accident and emergency
More informationInteraction between Sedation and Weaning: How to Balance Them? Guillermo Castorena MD Fundacion Clinica Medica Sur Mexico
Interaction between Sedation and Weaning: How to Balance Them? Guillermo Castorena MD Fundacion Clinica Medica Sur Mexico Balance is not that easy! Weaning Weaning is the liberation of a patient from
More informationManagement of Dyspnea and Cough in Lung Cancer
Management of Dyspnea and Cough in Lung Cancer Dr. Chris Ogaranko Lung Cancer Educational Event November 2013 Presenter Disclosure Faculty: Dr. Chris Ogaranko Relationships with commercial interests: Grants/Research
More informationManaging Pain in the Elderly
Managing Pain in the Elderly MILES BELGRADE, MD COMPREHENSIVE PAIN CENTER MINNEAPOLIS VA The Pain Deck is Stacked Against the Elderly Osteoporosis Fractures 1 Zoster & PHN Trigeminal Neuralgia Verne 81-year-old
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationLearning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16
Acute Pain in the Chronic Pain Patient for Ambulatory Surgery Danielle Ludwin, MD Associate Professor of Anesthesiology Division of Regional and Orthopedic Anesthesia Columbia University Medical Center
More informationRenal Palliative Care Last Days of Life
Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr
More informationPain Management in Hospice and Palliative Care
Pain Management in Hospice and Palliative Care A Case-based Approach JoAnne Nowak, M.D. Merrimack Valley Hospice Revised November 2011 Objectives Use a case study approach to stimulate discussion and illustrate
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationDyspnea: Evaluation and Management
Dyspnea: Evaluation and Management Sandra Whitlock, M.D. Four Seasons Palliative Care Course Handouts & Post Test o To download presentation handouts, click on the attachment icon o Presenter discloses
More informationWhat to do when you are called to see a patient with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2018
What to do when you are called to see a patient with... PAIN Susan Merel, MD Division of General Internal Medicine July 2018 Disclosures Susan Merel has no relationships with any entity producing, marketing,
More informationEquianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine
Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain
More informationGUIDELINES ON PAIN MANAGEMENT IN UROLOGY
GUIDELINES ON PAIN MANAGEMENT IN UROLOGY F. Francesca (chairman), P. Bader, D. Echtle, F. Giunta, J. Williams Eur Urol 2003; 44(4):383-389 Introduction Pain is defined as an unpleasant sensory and emotional
More informationAmber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center
Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of
More informationPalliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015
Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015 Objectives Define palliative care and primary palliative care Describe the rationale for providing primary palliative care in
More informationPain: What You Need to Know to Advocate
Pain: What You Need to Know to Advocate Amy M. Corcoran, MD Assistant Professor of Clinical Medicine Department of Medicine, Division of Geriatrics University of Pennsylvania Associate Medical Director
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More informationE-Learning Module N: Pharmacological Review
E-Learning Module N: Pharmacological Review This Module requires the learner to have read Chapter 13 of the Fundamentals Program Guide and the other required readings associated with the topic. Revised:
More informationNon Malignant Pain: Symptom Management
Non Malignant Pain: Symptom Management Renal Care Symposium July 2018 Anica Vasic Pain Management Unit St George Hospital Definitions Prevalence Assessment Treatment Medications Newer agents: tapentadol,
More informationPain Management in the
Pain Management in the Elderly Meri Hix, PharmD, CGP, BCPS Associate Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy No conflicts of interest to declare Objectives Discuss
More informationPalliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre
Palliative Care and the Critical Role of the Pharmacist Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre Overview What is palliative care Role of a pharmacist in palliative care Issues
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More informationGeriatric Pain Assessment and Management. Robin Arends, DNP, CNP, FNP-BC
+ Geriatric Pain Assessment and Management Robin Arends, DNP, CNP, FNP-BC + Objectives List three reasons why elderly are less likely to report pain. List three barriers to pain management Describe two
More informationPain and the MGH Promise
Pain is an unpleasant sensory & emotional experience associated with actual or potential tissue damage or described in terms of such damage Our promise to patients we will always: Work as a team to evaluate,
More informationCare in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More informationObjectives: What is your Definition of Pain? 8/16/2017
Safe Opioid Management for the Seriously Ill Patient Sam Perna, D.O. Objectives: MDB1 1) Participants will understand the way the body s pain system works. 2) Participants will identify the elements of
More informationScreening - inclusion criteria
PAIN OUT Community research EU ROP EAN COMMISSION A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Room number: Screening
More informationPAIN MANAGEMENT IN UROLOGY
24 PAIN MANAGEMENT IN UROLOGY F. Francesca (chairman), P. Bader, D. Echtle, F. Giunta, J. Williams Eur Urol 2003; 44(4):383-389 Introduction Pain is defined as an unpleasant sensory and emotional experience
More informationLumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
More informationPain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN
Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing
More informationIntractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat.
Difficult Pain Syndrome/Intractable/Refractory Pain Intractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat. Reasonable efforts Differs for specialties/regions/countries
More informationMitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly
Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly Mary Lynn McPherson, PharmD, MDE, MA, BCPS, CPE Professor and Executive Director, Advanced Post-Graduate
More informationThe Pain of a Fractured Neck of Femur. Ms Fiona Nielsen- Project Lead
The Pain of a Fractured Neck of Femur - Project Lead Our health service 75,000 in-patients 165,000 out-patients 900 beds 6,200 staff 70,000 emergency attendances #NOF Presentations 2010-2011- 262 2011-2012-
More informationPain Control After Surgery. Patient Information
Pain Control After Surgery Patient Information What is Pain? Pain is an uncomfortable feeling that tells you something may be wrong in your body. Pain is your body s way of sending a warning to your brain.
More informationI have no financial disclosures.
Palliative Medicine: Year(s) in Review I have no financial disclosures. Lynn A Flint, MD Staff Physician, SFVAMC Assistant Clinical Professor Division of Geriatrics Advances in Internal Medicine 2012 2
More informationAgenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures
Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT Case Discussions August 26, 2014 PCSS MAT Webinar Sponsored by the American Psychiatric Association Daniel P. Alford, MD,
More informationChoose a category. You will be given the answer. You must give the correct question. Click to begin.
Instructions for using this template. Remember this is Jeopardy, so where I have written Answer this is the prompt the students will see, and where I have Question should be the student s response. To
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation
More informationScreening - inclusion criteria
A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Patient code (local): Room number: Screening - inclusion criteria
More informationPain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine
Pain November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Objectives To be able to define pain To be able to evaluate pain To be able to classify types of pain To learn appropriate
More informationManaging Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.
Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any
More informationManaging Care at End of Life:
Managing Care at End of Life: Physical Suffering Pain & Dyspnea Verna Sellers, MD, MPH, AGSF Medical Director Centra PACE Lynchburg, Virginia 1 Speaker Disclosures: Dr. Sellers has disclosed that she has
More informationPRACTICAL DYSPNEA MANAGEMENT Margot Sondermann BScPT, MEd. Palliative Consultant for End-Stage Lung Disease, Calgary Zone
PRACTICAL DYSPNEA MANAGEMENT Margot Sondermann BScPT, MEd. Palliative Consultant for End-Stage Lung Disease, Calgary Zone Faculty / Presenter Disclosure Faculty: Margot Sondermann Relationships with commercial
More informationFighting the Good Fight: How to Convert Opioids Just Right!
Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,
More informationResponding to The Joint Commission Alert on Safe Use of Opioids in Hospitals
Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management The Johns Hopkins Hospital Objectives and Disclosures
More informationPain Module. Opioid-RelatedRespiratory Depression (ORRD)
Pain Module Opioid-RelatedRespiratory Depression (ORRD) Characteristics of patients who are at higher risk for Opioid- Related Respiratory Depression (ORRD) Sleep apnea or sleep disorder diagnosis : typically
More informationPalliative and Hospice Care of the Terminally Ill Introduction
Palliative and Hospice Care of the Terminally Ill Introduction There has been an increase in life expectancy for men and women of all races to 77.6 years Leading causes of death in older patients are chronic
More informationSymptom Management Challenges at End-of-Life
Symptom Management Challenges at End-of-Life Amanda Lovell, PharmD, BCGP Clinical Pharmacist- Inpatient Units Optum Hospice Pharmacy Services February 15, 2018 Hospice Pharmacy Services Objectives Identify
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationReview of Pain Management with Clinical and Regulatory Updates
Review of Pain Management with Clinical and Regulatory Updates Palliative Care Collaborative: 8 th Annual Regional Conference October 10, 2014 Michael Stellini, M.D.,M.S. Medical Director, Hospice and
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationHOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
More informationAppendix D: Drug Tables
Appendix D: Drug Tables A. Short-acting, Orally Administered Opioids Table D-1: Use of Short-acting, Orally Administered Opioids in Adults [198] Additional Maximum APAP dose: 4000 mg/d (2000 mg/d in chronic
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationAttach patient label here. Physician Orders ADULT: Palliative Care Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Palliative Care Phase, When to Initiate: Palliative Care Phase Admission/Transfer/Discharge Patient Status Initial
More informationWSHPCO. HOSPICE PHYSICIAN CHALLENGES October 2017 Panel Presentation
HOSPICE PHYSICIAN CHALLENGES October 2017 Panel Presentation Mimi Pattison, MD Hope Wechkin, MD Patrick Waber, MD Wayne Kohan, MD Finding the Right Hospice Diagnosis For the following cases, please consider
More informationObjectives. Symptom Management in the Frail Elderly Population. Disclosures. Symptom Management: Pain 12/05/2014
Objectives Symptom Management in the Frail Elderly Population Dr. Katie Marchington, MD, CCFP Palliative Care Physician Toronto Western Hospital Kensington Hospice To reflect on why we should identify
More informationPOST-INTUBATION ANALGESIA AND SEDATION. August 2012 J Pelletier
POST-INTUBATION ANALGESIA AND SEDATION August 2012 J Pelletier Intubated patients experience pain and anxiety Mechanical ventilation, endotracheal tube Blood draws, positioning, suctioning Surgical procedures,
More informationBREATHLESSNESS MANAGEMENT
Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many
More informationSCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults
SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults BACKGROUND The justification for developing these guidelines lies
More informationPain Management in Older Adults. Mary Shelkey, PhD, ARNP
Pain Management in Older Adults Mary Shelkey, PhD, ARNP Cause of Death/ Demographic and Social Trends Early 1900s Current Medicine's Focus Comfort Cure Cause of Death Infectious Diseases/ Communicable
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase: Pediatric Spine Surgery General Orders
- Phase: Pediatric Spine Surgery General Orders PHYSICIAN S Diagnosis Weight Allergies Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert
More informationCourse Handouts & Disclosure
COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation
More informationSymptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationThe pain of it all. Rod MacLeod MNZM. Hibiscus Hospice, Auckland and University of Auckland
The pain of it all Rod MacLeod MNZM Hibiscus Hospice, Auckland and University of Auckland Definition of PAIN An unpleasant sensory and emotional experience which we primarily associate with tissue damage
More informationApproach to symptom control near the end-of-life
Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition
More informationGoals for sedation during mechanical ventilation
New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine
More information2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~
2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio 43130 (740) 687-8000 ~ www.fmchealth.org Introduction The purpose of this module is to reduce the risk of adverse outcomes for adult patients
More informationNYSPFP Kickoff. Reducing Adverse Drug Events from Opioids. April 6, 2017
NYSPFP Kickoff Reducing Adverse Drug Events from Opioids April 6, 2017 I have no financial relationships with drug companies, durable medical equipment companies or other for profit entities related to
More informationDyspnea: The top things you need to you know! Dr. Megan Sellick & Dr. Lawrence Lee Edmonton Zone Palliative Care Program
: The top things you need to you know! Dr. Megan Sellick & Dr. Lawrence Lee Edmonton Zone Palliative Care Program Faculty / Presenter Disclosure Faculty: Dr. Lawrence Lee Relationships with commercial
More informationIntraspinal (Neuraxial) Analgesia Community Nurses Competency Test
Intraspinal (Neuraxial) Analgesia Community Nurses Competency Test 1 Intraspinal (Neuraxial) Analgesia for Community Nurses Competency Test 1) Name the two major classifications of pain. i. ii. 2) Neuropathic
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationUse of PCA devices in Difficult Populations
Use of PCA devices in Difficult Populations Diane M. Santangelo MS RN ANP-C Stony Brook University Medical Center Acute Pain Service September 10, 2011 1 PCA technology? Why Bother? Costly Nurses complain:
More informationPain Management in Medical Dermatology
Pain Management in Medical Dermatology Robert G. Micheletti, MD Assistant Professor of Dermatology and Medicine Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center Co-Director, Inpatient Dermatology
More informationDisclosure. Relationships with commercial interests:
Disclosure Faculty: Jordi Perez Relationships with commercial interests: Grants/Research Support: None to declare Speakers Bureau/Honoraria: None to declare Consulting Fees: None to declare 1.Epidemiology
More informationSam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation
Sam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation Trust Overview Which drugs? How much? How to give? Adverse
More informationPain Assessment & Management. For General Nursing Orientation
Pain Assessment & Management For General Nursing Orientation April 2012 Overview Definition of pain Barriers to effective pain management Types of pain Objective pain assessment Approaches to management
More information